Sellwin Traders (538875)
TurnaroundFairStock Score: 3/100 — RISKY
Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹27.26 |
| Market Cap | ₹612.7 Cr |
| P/E Ratio | 21.59 |
| ROCE | 8.25% |
| ROE | 11.03% |
| Dividend Yield | 0% |
| Profit Growth | -25% |
| Debt/Equity | — |
| Sales Growth | -25.55% |
| 52-Week Range | ₹4.45 — ₹27.26 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹2.47 |
Strengths
- Company remains profitable with a positive ROE of 11.03% despite declining sales
- Latest quarter still generated net profit of ₹1 Cr on sales of ₹13 Cr
- Book value is positive at ₹2.47 per share, providing a floor (though far below price)
- Trading close to 52-week high suggests strong market interest and liquidity
Concerns
- Sales and profits both declined 25% year-on-year, showing fundamental deterioration
- P/E of 21.59 and P/B of 11.04 are expensive for a business with negative growth
- Piotroski F-Score of 3/9 indicates weak financial health and potential red flags
- Zero dividend yield offers no income cushion to investors
AI Analysis
Let me look at Sellwin Traders with the cold eye Graham taught me. The stock sits at ₹27.26, having rocketed from ₹4.45 in the last 52 weeks. But what has the business done? Sales have fallen 25.55% and profits have fallen 25.00%. Yet the market is paying a P/E of 21.59 and a P/B of 11.04 for this shrinking enterprise. Book value is a mere ₹2.47 per share, so I am paying over eleven times assets for a company earning an 11% return on those assets. That is not investment; that is hope. The Piotroski F-Score of 3/9 is a red flag, signalling poor financial health. There is no dividend to comfort me while I wait. The latest quarter shows sales of ₹13 Cr and net profit of ₹1 Cr – small numbers that do not support a ₹613 Cr market cap. Even if I assume the business stabilises, the current price already prices in a brilliant future. Where is my margin of safety? It is nowhere to be found. In Graham's language, this is speculation disguised as growth. The price action may tempt a trader, but as a value investor I demand a reasonable price for demonstrated earning power, not for a story. The negative growth, high valuation, and low accounting quality score tell me to keep my money parked elsewhere. I would rather miss a speculative rally than risk permanent capital on a business whose fundamentals are deteriorating while the stock price balloons. This is not the kind of compounder I seek; it is a risky momentum act.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer